RxDoctor Payments DataLook up a doctor →

Lindsey Roeker, MD

Hematology · Rochester, MNNPI 1497168538

Payments from drug & device makers

$9,661,694in general payments, 2019–2025

Across 268 payments — averaging $36,051 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$6.3M
  • Genentech, Inc.$2.1M
  • AstraZeneca$938K
  • Adaptive Biotechnologies Corporation$271K
  • AbbVie$23K
  • Janssen Global Services, LLC$14K
  • plus $37K from 10 others
$26,444in research payments, 2019–2025

Across 2 payments — averaging $13,222 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$26K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,661,694 in reported general payments places this provider in the 95th percentile of 111 hematology providers in Minnesota.

See all hematology providers in Minnesota

Medicare billing

Part B allowed, 2024
$84,767
Medicare patients
217
Services billed
896

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →